Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China

PharmacoEconomics

Volumn 32, Issue 3, 2014, Pages 305-313

  Wu, Eric Q ^a   Xie, Jipan ^a   Wu, Chun ^b   Du, Ella Xiaoyan ^a   Li, Nanxin ^a   Tan, Ruoding ^a   Liu, Yuanli ^c  

^a ANALYSIS GROUP   (United States)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; RIVAROXABAN; WARFARIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CHINA; COMORBIDITY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; ECONOMIC EVALUATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; SURGICAL TECHNIQUE; VENOUS THROMBOEMBOLISM; ECONOMICS; HEALTH CARE COST; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ANTICOAGULANTS; CHINA; FEMALE; HEALTH CARE COSTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LOGISTIC MODELS; MALE; MIDDLE AGED; MORPHOLINES; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; THIOPHENES; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84896319890     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-014-0131-4     Document Type: Article

References (22)

1. Burnett B. Management of venous thromboembolism. Prim Care. 2013;40(1):73-90.
2. Garcia P, Ruiz W, Loza Munarriz C. Warfarin initiation nomograms for venous thromboembolism. Cochrane Database Syst Rev. 2013;7:CD007699.
3. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol. 2011;86(2):217-20.
4. Surgeon General. Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism; 2008. http://www.surgeongeneral.gov/library/ calls/deepvein/index.html. Accessed 10 Oct 2013.
5. Zhai ZG, Zhan X, Yang YH, Wang C. Recent research on venous thromboembolism in China: a brief report from China Venous Thromboembolism Study Group. Chin Med J (Engl). 2010;123(4):485-90.
6. Sun KK, Wang C, Pang BS, Yang YH, He W, Chen TF, et al. Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients [in Chinese]. Chin J Epidemiol. 2004;25(12):1019-23.
7. Guan ZP, Lu HS, Chen YZ, Song YN, Qin XL, Jiang J. Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty [in Chinese]. Chin J Surg. 2005;43(20):1317-20.
8. Li XY, Fan J, Cheng YQ, Wang Y, Yao C, Zhong NS. Incidence and prevention of venous thromboembolism in acutely ill hospitalized elderly Chinese. Chin Med J (Engl). 2011;124(3):335-40.
9. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S-47S.
10. Hull R, Hirsh J, Jay R, Carter C, England C, Gent M, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med. 1982;307(27):1676-81. (Pubitemid 13206049)
11. Oake N, Jennings A, Forster AJ, Fergusson D, Doucette S, van Walraven C. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ. 2008;179(3):235-44.
12. Rivaroxaban Chinese label as approved by China Food and Drug Administration. http://www.xarelto.com.cn/html/downloads/SPC-CN.pdf. Accessed 30 Dec 2013.
13. China Thoracic Society. The guideline of diagnosis and treatment of pulmonary thromboembolism in China [in Chinese]. Chin J Tuberc Respir Dis. 2001;24:259-64.
14. China Medical Association. The diagnosis and treatment of deep vein thrombosis [in Chinese]. Chin J Gen Surg. 2008;23(3):235-8.
15. Tsai J, Abe K, Boulet SL, Beckman MG, Hooper WC, Grant AM. Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism. PLoS ONE. 2013;8(7):e70061.
16. National Bureau of Statistics of China. China Statistical Database; 2013. http://www.stats.gov.cn/english/. Accessed 10 Oct 2013.
17. Bloomberg. US Dollar - China RMB exchange rate; 2013. http://www.bloomberg.com/quote/USDCNY:CUR. Accessed 10 Oct 2013.
18. Tan XY, He JG, Zou ZP, Zhao YF, Chen BP, Gao Y, et al. Changes of the proportion and mortality of pulmonary thromboembolism in hospitalized patients from 1974 to 2005. Chin Med J (Engl). 2006;119(12):998-1002. (Pubitemid 43960080)
19. Kapoor A, Labonte AJ, Winter MR, Segal JB, Silliman RA, Katz JN, et al. Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and cooccurring comorbidities in the Nationwide Inpatient Sample (2003-2006). BMC Geriatr. 2010;10:63.
20. Xie Y, Zhang X, Li J, Yu X, Ren Q. China Well-being Development Report 2013. Beijing: Peking University Press; 2013.
21. Wu JJ, Yang L. Analysis of hospitalization costs for 278 venous thromboembolism patients with health insurance in China [in Chinese]. J Peking Univ (Health Sci). 2013;45(3):437-42.
22. Gong IY, Schwarz UI, Crown N, Dresser GK, Lazo-Langner A, Zou G, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med. 2008;358(10):999-1008. (Pubitemid 351347099)